PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+18.66%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.3B
AUM Growth
+$1.3B
Cap. Flow
+$50.8M
Cap. Flow %
3.91%
Top 10 Hldgs %
53.38%
Holding
188
New
39
Increased
28
Reduced
33
Closed
30

Top Buys

1
AGN
Allergan plc
AGN
$45.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
$21.1M
3
BAX icon
Baxter International
BAX
$16.2M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
$13.8M
5
CTMX icon
CytomX Therapeutics
CTMX
$13.4M

Top Sells

1
NBIX icon
Neurocrine Biosciences
NBIX
$25.3M
2
SRPT icon
Sarepta Therapeutics
SRPT
$21M
3
RLYP
RELYPSA INC COM
RLYP
$18.3M
4
CEMP
Cempra, Inc.
CEMP
$16.2M
5
SHPG
Shire pic
SHPG
$8.42M

Sector Composition

1 Healthcare 89.63%
2 Consumer Discretionary 0.08%
3 Financials 0.04%
4 Consumer Staples 0.02%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CSBR icon
76
Champions Oncology
CSBR
$95.8M
$1.33M 0.1%
372,597
– –
NVTA
77
DELISTED
Invitae Corporation
NVTA
$1.18M 0.09%
143,366
-108,300
-43% -$889K
SAGE
78
DELISTED
Sage Therapeutics
SAGE
$1.17M 0.09%
20,000
– –
GNVC
79
DELISTED
GenVec, Inc.
GNVC
$1.13M 0.08%
615,844
– –
SCYX icon
80
SCYNEXIS
SCYX
$35.2M
$1.09M 0.08%
175,000
– –
ALPN
81
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$968K 0.07%
125,000
– –
CGNT
82
DELISTED
Cogentix Medical, Inc.
CGNT
$869K 0.06%
673,257
– –
STLA icon
83
Stellantis
STLA
$26.4B
$867K 0.06%
62,000
– –
VCEL icon
84
Vericel Corp
VCEL
$1.69B
$789K 0.06%
305,662
-45,500
-13% -$117K
NGNE icon
85
Neurogene
NGNE
$284M
$744K 0.06%
59,600
– –
VNDA icon
86
Vanda Pharmaceuticals
VNDA
$279M
$669K 0.05%
+71,849
New +$669K
XIV
87
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
$645K 0.05%
25,000
-21,500
-46% -$555K
IMMU
88
DELISTED
Immunomedics Inc
IMMU
$614K 0.05%
+200,000
New +$614K
DRNA
89
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$594K 0.04%
50,000
– –
GRCE
90
Grace Therapeutics, Inc. Common Stock
GRCE
$41.1M
$594K 0.04%
236,559
-2,129,041
-90% –
ANIP icon
91
ANI Pharmaceuticals
ANIP
$2.06B
$578K 0.04%
12,800
-6,456
-34% -$292K
GLMD icon
92
Galmed Pharmaceuticals
GLMD
$7.07M
$571K 0.04%
75,000
– –
NVO icon
93
Novo Nordisk
NVO
$252B
$554K 0.04%
9,540
+4,200
+79% +$244K
STML
94
DELISTED
Stemline Therapeutics, Inc.
STML
$496K 0.04%
78,603
– –
AVGR
95
DELISTED
Avinger, Inc. Common Stock
AVGR
$444K 0.03%
-77,934
Closed -$1.43M
MACK
96
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$395K 0.03%
+50,000
New +$395K
TRIL
97
DELISTED
Trillium Therapeutics Inc.
TRIL
$378K 0.03%
30,000
– –
AKAO
98
DELISTED
Achaogen, Inc.
AKAO
$344K 0.03%
60,000
– –
APYX icon
99
Apyx Medical
APYX
$71.9M
$342K 0.03%
162,700
– –
ARIA
100
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$313K 0.02%
50,000
-400,000
-89% -$2.5M
2 3
4
5 6